Upadacitinib for the treatment of alopecia areata and severe atopic dermatitis in a paediatric patient: A case report-Reference-Cited by-同舟云学术

Upadacitinib for the treatment of alopecia areata and severe atopic dermatitis in a paediatric patient: A case report

Published:2022-01 Issue: Volume:10 Page:2050313X2211384
ISSN:2050-313X
Container-title:SAGE Open Medical Case Reports
language:en
Short-container-title:SAGE Open Medical Case Reports

Author:

Bourkas Adrienn N¹²^ORCID,Sibbald Cathryn²³

Affiliation:

1. School of Medicine, Queen’s University, Kingston, ON, Canada

2. Division of Dermatology, Department of Paediatrics, The Hospital for Sick Children, Toronto, ON, Canada

3. Division of Dermatology, Department of Medicine, University of Toronto, Toronto, ON, Canada

Abstract

This case report describes the first successful treatment of alopecia areata and atopic dermatitis with the Janus kinase 1 inhibitor upadacitinib in a paediatric patient. After minimal response to topical corticosteroids and spironolactone, improvements in hair growth on the scalp and body were noted after only 6 weeks of upadacitinib treatment.

Publisher

SAGE Publications

Subject

General Medicine

Link

http://journals.sagepub.com/doi/pdf/10.1177/2050313X221138452

Reference13 articles.

1. Evaluation of the Prevalence and Incidence of Pediatric Alopecia Areata Using Electronic Health Record Data

2. Comorbidities in pediatric alopecia areata

3. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys

4. Diagnosis and Management of Atopic Dermatitis: A Review

5. Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double-blind, randomised controlled phase 3 trials

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cyclosporine-induced alopecia:a case report, FDA adverse event reporting system analysis and literature assessment;Frontiers in Pharmacology;2024-08-28

2. Drug-Induced Alopecia Areata From Upadacitinib;Cureus;2024-08-11

3. Transgenerational hormesis in healthy aging and antiaging medicine from bench to clinics: Role of food components;Mechanisms of Ageing and Development;2024-08

4. Evaluation of the Safety and Effectiveness of Oral Minoxidil in Children: A Systematic Review;Dermatology and Therapy;2024-06-11

5. Abrocitinib Improved Dupilumab-Resistant Severe Atopic Dermatitis with Comorbid Mild Alopecia Areata in a 12-Year-Old Boy: A Case Report with 1-Year Follow-Up;Journal of Asthma and Allergy;2024-04